Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB00918_nanopub.RAydQc1LXWtnd09uXFRYBYVzFtnOW-RqTqcFdxd4mpJV0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB00918 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00918 label "DDI between Zolmitriptan and Almotriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and almotriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. [drugbank_resource:DB00315_DB00918]" assertion.
- drugbank_resource:DB00315_DB00918 identifier "drugbank_resource:DB00315_DB00918" assertion.
- drugbank_resource:DB00315_DB00918 title "DDI between Zolmitriptan and Almotriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and almotriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated." assertion.
- drugbank:DB00918 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00918 assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00918 assertion.